IL17A and chronic obstructive pulmonary disease: The increased expression of IL-17A in the lung tissues of COPD patients was found to be negatively associated with the clinical evaluation indexes of lung function, such as forced expiratory volume in 1 s (FEV1%), forced vital capacity (FVC %) and FEV1/FVC (Zheng et al., 2018).